Additionally, downregulation of SHANK1 exacerbates synaptic dysfunction and cognitive deficits, while upregulation of the PKA/CREB pathway increases SHANK1 expression, thereby improving synaptic damage and mitigating cognitive deficits. Here, SHANK1 is linked to Cognitive impairment.